Vaxart, Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Vaxart, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Vaxart, Inc. Return On Equity for the quarter ending September 30, 2024 was -110 %, a 10.7% decline year-over-year.
  • Vaxart, Inc. annual Return On Equity for 2023 was -108 %, a 36.5% decline from 2022.
  • Vaxart, Inc. annual Return On Equity for 2022 was -79.5 %, a 117% decline from 2021.
  • Vaxart, Inc. annual Return On Equity for 2021 was -36.7 %, a 7.05% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -110 -10.7 -10.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 -114 -15.2 -15.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -121 -28.5 -30.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -108 -29 -36.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -99.7 -32.2 -47.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -99 -46.1 -87.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -92.6 -50.6 -121% Jan 1, 2023 Mar 31, 2023
Q4 2022 -79.5 -42.8 -117% Oct 1, 2022 Dec 31, 2022
Q3 2022 -67.6 -31.5 -87.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -52.9 -18.7 -54.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -42 -2.14 -5.38% Jan 1, 2022 Mar 31, 2022
Q4 2021 -36.7 +2.78 +7.05% Oct 1, 2021 Dec 31, 2021
Q3 2021 -36.1 +9.73 +21.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -34.3 +50.6 +59.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -39.8 +54.4 +57.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -39.5 +84.3 +68.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -45.8 +71.3 +60.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -84.9 +47.6 +35.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -94.2 +45.3 +32.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -124 -34.4 -38.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -117 +67.5 +36.6% Jul 1, 2019 Sep 30, 2019
Q2 2019 -133 +4.44 +3.24% Apr 1, 2019 Jun 30, 2019
Q1 2019 -139 -67.9 -94.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -89.3 +123 +57.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -185 +74.7 +28.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -137 +67.1 +32.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -71.6 +78.3 +52.2% Jan 1, 2018 Mar 31, 2018
Q4 2017 -212 -93.4 -78.7% Oct 1, 2017 Dec 31, 2017
Q3 2017 -259 -200 -334% Jul 1, 2017 Sep 30, 2017
Q2 2017 -204 -158 -342% Apr 1, 2017 Jun 30, 2017
Q1 2017 -150 -87.1 -139% Jan 1, 2017 Mar 31, 2017
Q4 2016 -119 -71.9 -154% Oct 1, 2016 Dec 31, 2016
Q3 2016 -59.7 -34.4 -136% Jul 1, 2016 Sep 30, 2016
Q2 2016 -46.2 -21.7 -88.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -62.8 -51.4 -449% Jan 1, 2016 Mar 31, 2016
Q4 2015 -46.8 -38.1 -442% Oct 1, 2015 Dec 31, 2015
Q3 2015 -25.3 -8.1 -47% Jul 1, 2015 Sep 30, 2015
Q2 2015 -24.5 -10.4 -74% Apr 1, 2015 Jun 30, 2015
Q1 2015 -11.4 -1.48 -14.9% Jan 1, 2015 Mar 31, 2015
Q4 2014 -8.62 +6.24 +42% Oct 1, 2014 Dec 31, 2014
Q3 2014 -17.2 -9.56 -125% Jul 1, 2014 Sep 30, 2014
Q2 2014 -14.1 -0.25 -1.81% Apr 1, 2014 Jun 30, 2014
Q1 2014 -9.96 -1.69 -20.4% Jan 1, 2014 Mar 31, 2014
Q4 2013 -14.9 -1.91 -14.7% Oct 1, 2013 Dec 31, 2013
Q3 2013 -7.67 +27.6 +78.2% Jul 1, 2013 Sep 30, 2013
Q2 2013 -13.9 +5.19 +27.3% Apr 1, 2013 Jun 30, 2013
Q1 2013 -8.27 +12 +59.2% Jan 1, 2013 Mar 31, 2013
Q4 2012 -13 Oct 1, 2012 Dec 31, 2012
Q3 2012 -35.2 Jul 1, 2012 Sep 30, 2012
Q2 2012 -19 Apr 1, 2012 Jun 30, 2012
Q1 2012 -20.3 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.